|Bid||76.89 x 900|
|Ask||76.93 x 900|
|Day's Range||76.76 - 77.63|
|52 Week Range||51.51 - 82.55|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||65.30|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
TMO vs. EW: Which Stock Is the Better Value Option?
Despite coronavirus-hit sales, Edwards Lifesciences (EW) witnessed steady improvement in TAVR procedure volumes in Q2. Regulatory approvals look encouraging.
Investors might not be overly excited about Edwards Lifesciences' (NYSE: EW) stock performance so far in 2020. Edwards Lifesciences announced its second-quarter results after the market closed on Thursday, and the stock jumped 5% in after-hours trading.